Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NJ/Trenton
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Trenton, NJ

Studies commonly pay $75 to $4,500 per completed study

2,339 clinical trials are currently recruiting participants within 30 miles of Trenton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,339studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Trenton right now

Top 25 of 2,339 recruiting studies, sorted by proximity — each links to its official registry page

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Acute Leukemia, Acute Myeloid Leukemia N/A Interventional 50 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Children's Hospital of Philadelphia
See eligibility & contact on ClinicalTrials.gov (NCT03810196)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital — New Brunswick, New Jersey (24.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Hematuria - Cause Not Known N/A Interventional 1,000 participants sought
Summit Health — Voorhees Township, New Jersey (22.8 mi) · Sponsor: Pacific Edge Limited
See eligibility & contact on ClinicalTrials.gov (NCT06394869)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131) — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma Recurrent Phase 2 Interventional 54 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT07085338)

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps N/A Interventional 300 participants sought
University of Pennsylvania — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Airiver Medical, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07290140)

One-Time DNA Study for Vasculitis

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis N/A Observational 1,000 participants sought
University of Pennsylvania — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: University of Pennsylvania
See eligibility & contact on ClinicalTrials.gov (NCT01241305)

Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)

Stroke, Cerebrovascular Accident N/A Interventional 150 participants sought
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute — Edison, New Jersey (27.5 mi) · Sponsor: Hackensack Meridian Health
See eligibility & contact on ClinicalTrials.gov (NCT05651945)

Adaptive Radiation for Abdominopelvic Metastases

Neoplasm - Soft Tissue Pelvis Malignant Secondary, Malignant Neoplasm of Stomach Phase 1 Interventional 30 participants sought
Fox Chase Cancer Center — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Fox Chase Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT05880667)

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Phase 1 Interventional 9 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Rocket Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05885412)

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Crohn Disease N/A Interventional 60 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Seattle Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06216899)

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Chronic Graft-versus-host Disease (cGVHD) Phase 2 Interventional 120 participants sought
Fox Chase Cancer Center — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT06660355)

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) Phase 1 Interventional 30 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Stephan Grupp MD PhD
See eligibility & contact on ClinicalTrials.gov (NCT07464951)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Fox Chase Cancer Center — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Carcinoma, Non-Small-Cell Lung Phase 1, Phase 2 Interventional 450 participants sought
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT04165070)

OssiMend BA in Posterolateral Instrumented Lumbar Fusion

Spinal Disease, Degenerative Disc Disease N/A Observational 120 participants sought
University Orthopaedic Associates, Division of OrthoNJ — Somerset, New Jersey (23.8 mi) · Sponsor: Collagen Matrix
See eligibility & contact on ClinicalTrials.gov (NCT04775537)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought
Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey (24.5 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06465329)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Abington, Pennsylvania (20.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

Osteoporotic Fractures, Osteoporosis N/A Observational 648 participants sought
Thomas Jefferson University Hospital — Philadelphia, Pennsylvania (28.2 mi) · Sponsor: AO Foundation, AO Spine
See eligibility & contact on ClinicalTrials.gov (NCT07027306)
Actively enrolling

Studies you may be able to join near Trenton

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Trenton

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

New Jersey Clinical Trials

★ 5.0
100 Campus Town Circle Ste 103 #154, Ewing Township, NJ 08638
(646) 265-1865

Premier Research

708 Chambers St, Trenton, NJ 08611
(609) 392-6666

Trialfinity Clinical Research Center

1245 Whitehorse Mercerville Rd Ste 410-411, Hamilton Township, NJ 08619
(609) 450-3535

R-Research

★ 3.2
1374 Whitehorse Hamilton Square Rd #104, Hamilton Township, NJ 08690
(609) 585-4268
"Dr. Rizvi makes his decisions purely data-driven. Sometimes that works but other times, a data-driven answer is incomprehensible since each person's …"
— Don Zuby, 3★

Bioluminux Clinical Research New Jersey

★ 3.0
2131 NJ-33, Trenton, NJ 08690
(609) 613-6859

Princeton Center for Clinical Research

24 Vreeland Dr Ste 2, Skillman, NJ 08558
(800) 325-2202

Clinical Research Philadelphia

★ 4.2
9501 Roosevelt Blvd #208, Philadelphia, PA 19114
"If you ever thought of participating in any type of medical research study, don't' hesitate to check out Clinical Research Philadelphia. They have m…"
— Chris Pez, 5★

Clinical Research Philadelphia - Pennington

★ 5.0
21 NJ-31 Ste a8, Pennington, NJ 08534
(215) 676-6696
"I really enjoyed my time there."
— Steven Kupecz, 5★

Center for Communications Research – Princeton

★ 4.8
805 Bunn Dr, Princeton, NJ 08540
(609) 924-4600

Clinical trials in Trenton: what's recruiting

The Trenton area currently has 2,339 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Trenton, the most active research areas are:

  • Cancer & Oncology13 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Trenton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Trenton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Trenton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Trenton pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Trenton?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Trenton safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Trenton, NJ?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Trenton?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Trenton

Other metros within reach

Philadelphia, PA2,171 Staten Island, NY4,282 Newark, NJ4,276 Allentown, PA228 Jersey City, NJ4,332 Paterson, NJ4,155 Brooklyn, NY4,279 New York, NY4,211

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Trenton Bladder Issues Due To Spinal Cord Injury in Trenton All conditions

More of NJ

Jersey City4,332 Newark4,276 Paterson4,155

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts